News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
870,888 Results
Type
Article (88038)
Company Profile (825)
Press Release (782003)
Multimedia
Podcasts (198)
Webinars (28)
Section
Business (233298)
Career Advice (4147)
Deals (39886)
Drug Delivery (151)
Drug Development (91439)
Employer Resources (205)
FDA (18402)
Job Trends (17430)
News (397986)
Policy (39976)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3014)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (149)
Alliances (56982)
ALS (182)
Alzheimer's disease (1802)
Antibody-drug conjugate (ADC) (351)
Approvals (18586)
Artificial intelligence (637)
Autoimmune disease (172)
Automation (39)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (204)
Biotechnology (490)
Bladder cancer (164)
Brain cancer (65)
Breast cancer (672)
Cancer (5097)
Cardiovascular disease (451)
Career advice (3572)
Career pathing (41)
CAR-T (309)
CDC (59)
Celiac Disease (2)
Cell therapy (842)
Cervical cancer (38)
Clinical research (77106)
Collaboration (1848)
Company closure (5)
Compensation (1185)
Complete response letters (73)
COVID-19 (2994)
CRISPR (99)
C-suite (888)
Cystic fibrosis (155)
Data (6353)
Decentralized trials (2)
Denatured (73)
Depression (152)
Diabetes (539)
Diagnostics (7244)
Digital health (48)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (305)
Drug pricing (227)
Drug shortages (36)
Duchenne muscular dystrophy (244)
Earnings (100245)
Editorial (65)
Employer branding (25)
Employer resources (173)
Events (135234)
Executive appointments (1035)
FDA (21631)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1571)
Gene editing (218)
Generative AI (67)
Gene therapy (683)
GLP-1 (1141)
Government (5452)
Grass and pollen (8)
Guidances (387)
Healthcare (20954)
HIV (63)
Huntington's disease (50)
IgA nephropathy (86)
Immunology and inflammation (297)
Immuno-oncology (63)
Indications (105)
Infectious disease (3285)
Inflammatory bowel disease (207)
Inflation Reduction Act (17)
Influenza (121)
Intellectual property (252)
Interviews (816)
IPO (17963)
IRA (60)
Job creations (5200)
Job search strategy (2866)
JPM (70)
Kidney cancer (17)
Labor market (94)
Layoffs (660)
Leadership (40)
Legal (10162)
Liver cancer (99)
Longevity (16)
Lung cancer (686)
Lymphoma (383)
Machine learning (45)
Management (66)
Manufacturing (866)
MASH (175)
Medical device (15047)
Medtech (15103)
Mergers & acquisitions (23003)
Metabolic disorders (1422)
Multiple sclerosis (170)
NASH (23)
Neurodegenerative disease (361)
Neuropsychiatric disorders (103)
Neuroscience (3147)
Neurotech (1)
NextGen: Class of 2026 (7709)
Non-profit (5113)
Now hiring (66)
Obesity (692)
Opinion (337)
Ovarian cancer (169)
Pain (218)
Pancreatic cancer (234)
Parkinson's disease (303)
Partnered (39)
Patents (515)
Patient recruitment (497)
Peanut (60)
People (66962)
Pharmaceutical (145)
Pharmacy benefit managers (33)
Phase 1 (23825)
Phase 2 (33461)
Phase 3 (25207)
Pipeline (5283)
Policy (340)
Postmarket research (3554)
Preclinical (10695)
Press Release (72)
Prostate cancer (251)
Psychedelics (57)
Radiopharmaceuticals (303)
Rare diseases (932)
Real estate (7442)
Recruiting (80)
Regulatory (29105)
Reports (67)
Research institute (2729)
Resumes & cover letters (651)
Rett syndrome (28)
RNA editing (21)
RSV (85)
Schizophrenia (160)
Series A (262)
Series B (199)
Service/supplier (30)
Sickle cell disease (104)
Special edition (27)
Spinal muscular atrophy (178)
Sponsored (48)
Startups (4334)
State (2)
Stomach cancer (20)
Supply chain (114)
Tariffs (101)
The Weekly (123)
Vaccines (1152)
Venture capital (98)
Weight loss (477)
Women's health (92)
Worklife (22)
Date
Today (103)
Last 7 days (627)
Last 30 days (2243)
Last 365 days (32811)
2026 (3199)
2025 (33230)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (92)
Alaska (7)
Arizona (344)
Arkansas (14)
Asia (51597)
Australia (9063)
California (11669)
Canada (3352)
China (1187)
Colorado (496)
Connecticut (506)
Delaware (351)
Europe (118557)
Florida (1715)
Georgia (375)
Hawaii (4)
Idaho (68)
Illinois (974)
India (70)
Indiana (549)
Iowa (24)
Japan (438)
Kansas (133)
Kentucky (43)
Louisiana (30)
Maine (83)
Maryland (1465)
Massachusetts (8585)
Michigan (363)
Minnesota (669)
Mississippi (6)
Missouri (141)
Montana (35)
Nebraska (29)
Nevada (127)
New Hampshire (86)
New Jersey (3134)
New Mexico (33)
New York (3082)
North Carolina (1624)
North Dakota (10)
Northern California (5596)
Ohio (357)
Oklahoma (23)
Oregon (55)
Pennsylvania (2330)
Puerto Rico (23)
Rhode Island (50)
South America (1664)
South Carolina (67)
South Dakota (1)
Southern California (4508)
Tennessee (177)
Texas (1842)
United States (42081)
Utah (351)
Vermont (1)
Virginia (292)
Washington D.C. (88)
Washington State (984)
West Virginia (4)
Wisconsin (131)
Wyoming (2)
870,888 Results for ")".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Embarrassingly, FASTA reduces Recomputable, Population-Scale Pangenomics from $100 (commercial preprocessing) to < $1 in compute cost per genome
February 9, 2026
·
1 min read
Press Releases
Trialt Announces Strategic Partnership with Medrio to Enhance Clinical Trial Data Management CRO Services Through New EDC Offering
February 9, 2026
·
1 min read
Press Releases
PreveCeutical Announces Filing of Patent for Delivery of CNS-Active Agents
February 9, 2026
·
7 min read
Press Releases
Optimi Health Completes MDMA Export for PTSD Treatment Under Australia’s Authorised Prescriber Scheme
February 9, 2026
·
1 min read
Press Releases
VectorY Therapeutics Announces First Participant Dosed in Phase 1/2 PIONEER-ALS Clinical Trial of VTx-002 in People with Amyotrophic Lateral Sclerosis (ALS)
February 9, 2026
·
1 min read
Mergers & acquisitions
Eli Lilly Enters CAR T Realm With $2.4B Orna Buy, Starting With Autoimmune
The deal gets Lilly access to Orna’s in vivo CAR T technology. The biotech’s lead asset, which has yet to start clinical testing, is focused on B cell–driven autoimmune diseases.
February 9, 2026
·
2 min read
·
Dan Samorodnitsky
Press Releases
Solid Biosciences Announces Positive Feedback from Type C Meeting with FDA for SGT-003 Gene Therapy for Duchenne Muscular Dystrophy
February 9, 2026
·
7 min read
Press Releases
Argá Medtech Reports 94% Lesion Durability and Strong Safety Profile in First-in-Human BURST-AF Trial of Single-Catheter PFA System
February 9, 2026
·
5 min read
Press Releases
4DMT Completes Enrollment for 4FRONT-1 Phase 3 Clinical Trial of 4D-150 in Wet AMD
February 9, 2026
·
8 min read
Press Releases
Trained Therapeutix Discovery Appoints Distinguished Industry Leaders to its Board of Directors
February 9, 2026
·
5 min read
1 of 87,089
Next
